Evidence map›Paper›PMID 39229597›Full record

ArticleFrontiers in veterinary science2024

Antiviral activity of SAFER

Thi Bich Ngoc Trinh, Elodie Lazenec, Thi Ngoc Ha Lai, Maria Matard-Mann, Luong Tan Phat, Anne Morvan, Anne-Cecile Delahaye, Pi Nyvall Collén, Thi Lan Nguyen, Van Phan Le

Abstract read
In one paragraph

Article in Frontiers in veterinary science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Thi Bich Ngoc Trinh *College of Veterinary Medicine, Vietnam National University of Agriculture (VNUA), Hanoi, Vietnam.
Elodie Lazenec *Olmix SA, Bréhan, France.
Thi Ngoc Ha LaiCollege of Veterinary Medicine, Vietnam National University of Agriculture (VNUA), Hanoi, Vietnam.
Maria Matard-MannOlmix SA, Bréhan, France.
Luong Tan PhatOlmix SA, Bréhan, France.
Anne MorvanOlmix SA, Bréhan, France.
Anne-Cecile DelahayeOlmix SA, Bréhan, France.
Pi Nyvall CollénOlmix SA, Bréhan, France.
Thi Lan NguyenCollege of Veterinary Medicine, Vietnam National University of Agriculture (VNUA), Hanoi, Vietnam.
Van Phan LeCollege of Veterinary Medicine, Vietnam National University of Agriculture (VNUA), Hanoi, Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

African swine fever (ASF) is one of the deadliest swine diseases, causing significant economic losses, threatening food security, and limiting pig production in affected countries. In the absence of an effective ASF vaccine, prevention and control of ASF depend mainly on effective biosecurity measures. In this study, the efficacy of SAFER

Indexed as

African swine feverantiviral activityASFVbody fluidsSAFER®

Identifiers

PMID39229597
PMCPMC11369675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.